Analysis of RNA-sequencing data from TCGA revealed that SHMT2 expression is elevated in ovarian cancer tissues, and high SHMT2 levels are associated with poor prognosis in patients (Wallace-Povirk et al., 2024, Zeng et al., 2021). This evidence concerns the gene SHMT2 and ovarian carcinoma.